Trypanosomiasis American
Mostrando 13-24 de 43 artigos, teses e dissertações.
-
13. Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors - how to make a dream come true
One hundred years ago, Carlos Chagas discovered a new disease, the American trypanosomiasis. Chagas and co-workers later characterised the disease's common manifestation, chronic cardiomyopathy, and suggested that parasitic persistence coupled with inflammation was the key underlying pathogenic mechanism. Better comprehension of the molecular mechanisms lead
Memórias do Instituto Oswaldo Cruz. Publicado em: 2009-07
-
14. Canine trypanosomiasis: etiology of infection and implications for public health
Canine trypanosomiasis, caused by protozoans of the genus Trypanosoma, is divided into two primary types: the American form (Chagas disease), due to Trypanosoma cruzi infection, and the African form (sleeping sickness or surra), provoked by Trypanosomaevansi. This disease was originally enzootic and affected only wild animals, including mammals and birds, wh
Journal of Venomous Animals and Toxins including Tropical Diseases. Publicado em: 2009
-
15. Determinantes progn?sticos de pacientes portadores de insufici?ncia card?aca cr?nica secund?ria ? cardiomiopatia da doen?a de Chagas na lista de espera para transplante card?aco.
No previous study has addressed the question of prognostic determinants for patients with Chagas? cardiomyopathy at the terminal stage listed for heart transplantation. Casuistic and Method: All patients listed for heart transplantation at our institution from August, 2000 to March, 2005 were considered for the study. Patients removed from the waiting list f
Publicado em: 2008
-
16. Inhibitor design for glyceraldehyde-3-phosphate dehydrogenase enzyme from Trypanosoma cruzi: structural biology and medicinal chemistry / Planejamento de inibidores da enzima gliceraldeído-3-fosfato desidrogenase de Trypanosoma cruzi: biologia estrutural e química medicinal
Parasitic diseases are the foremost threat to human health and welfare around the world. Chagasdisease (also called American trypanosomiasis) is a tropical parasitic disease which occurs in Latin America, particularly in South America. The currently available drugs for this parasitic disease have severe limitations, including poor efficacy and high toxicity.
Publicado em: 2008
-
17. An overview of Chagas disease treatment
Chagas disease (American trypanosomiasis) is endemic in 21 countries of the Americas, where control is largely focused on elimination of the domestic insect vectors (Triatominae) coupled with measures to extend and improve the screening of blood donors in order to avoid tranfusional transmission. Through national programmes and multinational initiatives coor
Memórias do Instituto Oswaldo Cruz. Publicado em: 21/09/2007
-
18. Determinantes prognósticos da cardiomiopatia chagásica na era atual do tratamento da insuficiência cardíaca crônica.
Conclusions: Lack of B-Blocking agent use, serum sodium levels <140mEq/L, left ventricular ejection fraction <0.32, digoxin treatment and New York Heart Association Class IV were powerful noninvasive independent predictors of all-cause mortality for patients with chronic heart failure secondary to Chagas cardiomyopathy in the current era of heart failure the
Publicado em: 2007
-
19. Desenvolvimento da forma farmacÃutica suspensÃo à base de benznidazol para utilizaÃÃo no tratamento da doenÃa de chagas
Chagasâ Disease or American trypanosomiasis is an endemic disease and exclusive ne-glectfulness of the American continent, mainly Central America and South America. Estimates allege that between 16 and 18 million people are infected by Trypanosoma cruzi. Benznidazol is currently the chemotherapeutically active ingredient against T. cruzi. Until 2003, benzni
Publicado em: 2006
-
20. Preditores de mortalidade geral em pacientes portadores de cardiopatia chagásica crônica tratados com cardioversor-desfibrilador implantável.
In most Chagas disease patients, sudden cardiac death is caused by Sustained Ventricular Tachycardia or Ventricular Fibrillation. Implantable Cardioverter Defibrillators have sporadically been used as a treatment for such arrhythmias in Chagas disease patients. This study aimed at determining predictors of all-cause mortality for Chagas disease patients rece
Publicado em: 2006
-
21. Doença de Chagas: indicadores cognitivos, de transtorno orgânico cerebral, de uso de álcool e qualidade de vida / Chagas Disease: cognitive evidences of organic cerebral disorder, problems related to the use of alcohol, and quality of life.
Chagas disease (American trypanosomiasis) is a protozoan infection caused by the flagellate Trypanosoma cruzi, which multiplies in the human body. Even though investigations on this subject are scarce, the relationship between psychological impairment and Chagas disease and its effect on the life and behavior of human reservoirs have already been acknowledge
Publicado em: 2006
-
22. Quantitative determination by HPLC of ent-kaurenoic and grandiflorenic acids in aerial parts of Wedelia paludosa D.C.
There are several reports of biological activity for kaurenoic acid (1), which is found in the aerial parts of Wedelia paludosa D.C., a herbaceous plant of the Asteraceae family abundant in Brazil, and that contains grandiflorenic acid (2) also. Both of these diterpenes were shown to cause lysis of trypomastigotes of the protozoa Trypanosoma cruzi, the causa
Revista Brasileira de Farmacognosia. Publicado em: 2005-06
-
23. Active transmission of human chagas disease in Colima Mexico
Despite efforts to eradicate American trypanosomiasis (AT) and Chagas disease from the Americas, there are still areas of active transmission that can eventually become a source of reinfection in previously controlled regions. Mexico could be one of those areas, where there are no formal preventive control programs despite the presence of communities infeste
Memórias do Instituto Oswaldo Cruz. Publicado em: 2004-06
-
24. Enfoques conceptuales y propuestas metodológicas para el estudio de las interacciones entre el medio ambiente y la salud: aplicación a un programa de investigación sobre la tripanosomiasis americana
Modifications of the landscape by human activity and migratory movements contribute to the emergence or reemergence of zoonotic and human diseases, particularly those transmitted by insects which often escape the changing environmental conditions, adapting and modifying their trophic networks and morphology, including their genotype. A better understanding o
Cadernos de Saúde Pública. Publicado em: 2003-08